Data Collection of Patients With Rare Bone Diseases
Launched by LUCA SANGIORGI · Feb 9, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The RD-DATA clinical trial is focused on collecting important information about patients with rare bone diseases, specifically conditions called skeletal dysplasias. This study aims to gather various types of data, such as personal health information, genetic details, and surgical histories, to better understand these diseases. By looking at how genetics might influence the symptoms and outcomes of these conditions, the researchers hope to gain insights that can improve care and treatment for patients.
Anyone with a rare disease that affects the bones may be eligible to participate, regardless of age or gender. However, individuals with conditions unrelated to these rare bone diseases will not be included. Participants in this study can expect to share their medical information, which will be used to help researchers learn more about the diseases. This trial is currently recruiting, and by joining, patients will contribute to important research that may lead to better understanding and management of skeletal dysplasias in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients affected by rare diseases with predominantly skeletal involvement
- Exclusion Criteria:
- • Any condition unrelated to rare diseases with predominantly skeletal involvement
About Luca Sangiorgi
Luca Sangiorgi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapies, Luca Sangiorgi leads initiatives that emphasize patient safety, scientific rigor, and ethical standards. The organization collaborates with leading research institutions and healthcare professionals to conduct clinical trials across various therapeutic areas, aiming to bring impactful treatments to market. Through strategic partnerships and a strong emphasis on data integrity, Luca Sangiorgi strives to enhance patient outcomes and contribute to the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, Emilia Romagna, Italy
Patients applied
Trial Officials
Luca Sangiorgi, MD, PhD
Principal Investigator
IRCCS istituto Ortopedico Rizzoli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials